People
Inflection Biosciences and AUM Biosciences Announce Global License Agreement for PIM/PI3K/mTOR Inhibitors
19 July 2019 - - Irish small molecule therapeutics developer Inflection Biosciences (Inflection) and Singapore-based AUM Biosciences, a company focused on the development of innovative and affordable ...
Lupus Therapeutics names new director
19 July 2019 - Lupus Therapeutics, an affiliate of The Lupus Research Alliance, has named Daniel Wallace, MD as its new director, it was reported yesterday.Dr Wallace is a renowned leader in clinical ...
PHAR names new vice president for Health Economics and Outcomes Research
19 July 2019 - PHAR LLC, a United States-based boutique health care consultancy that practices health economics and outcomes research, has named Mallik Greene, BPharm, PhD, DBA as its new vice preside...
Pandion Therapeutics Names Kakkar as Chief Executive Officer
18 July 2019 - - US-based biotechnology company Pandion Therapeutics, Inc has appointed Rahul Kakkar, MD, FACC as chief executive officer and as a member of the company's board of directors, the ...
Alzamend Neuro Names McDade to Its Scientific Advisory Board
17 July 2019 - - US-based Alzamend Neuro, Inc. has appointed Eric McDade, DO, a board-certified cognitive neurologist, as its next member to its scientific advisory board, the company said.
McDa...
Parvus Therapeutics Names Rienhoff as Chairman
17 July 2019 - - Canadian biopharmaceutical company Parvus Therapeutics has appointed Hugh Young Rienhoff, Jr., M.D., as chairman of the board, Charles A. Johnson, M.D., to the board of directors, and...